FDA approves new treatment for adults with partial-onset seizures

FDA approves new treatment for adults with partial-onset seizures

MHRA drug alert: recalls for 13 over-the-counter Ranitidine medicines

MHRA drug alert: recalls for 13 over-the-counter Ranitidine medicines

CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib

CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib

Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients...

Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations

Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate...

Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Alcohol Use Disorder
- Advertisement -

LATEST NEWS

MUST READ